A previous report in this journal has suggested that germline deletions in the proline-alanine-rich (PAPA-repeat) region of P57 (KIP2) are associated with increased risk of a variety of cancers, including breast cancer. We have analyzed the association of P57 PAPA-repeat deletion polymorphisms and breast cancer risk as part of a population-based case-control study of breast cancer. We have not observed an association between the presence of one or two copies of deletion polymorphisms in P57 and breast cancer risk (adjusted odds ratio: 1.1, 95% confidence interval: 0.6–2.0). Further investigation is necessary to determine the functional significance of P57 deletion polymorphisms and their potential relationship with disease.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Received: 9 September 1998 / Accepted: 26 October 1998
About this article
Cite this article
Li, Y., Millikan, R., Newman, B. et al. P57 (KIP2) polymorphisms and breast cancer risk. Hum Genet 104, 83–88 (1999). https://doi.org/10.1007/s004390050914
- Breast Cancer
- Confidence Interval
- Cancer Risk
- Breast Cancer Risk
- Adjusted Odds Ratio